Grants for Unrestricted

This grant provides funding to the International Labor Organization to combat child labor, forced labor, and improve working conditions in key supply chains across Brazil and other Latin American and Caribbean countries.

This funding opportunity provides financial support to Verite, Inc. to enhance fair labor practices and improve working conditions in the coffee industry, specifically targeting the eradication of child and forced labor in supply chains.

This funding opportunity is designed for researchers and organizations developing innovative technologies to detect, characterize, and permanently seal undocumented orphaned oil and gas wells, aiming to reduce methane emissions and environmental impacts.

Request for Information (RFI)The United States Agency for International Development in Bangladesh is in the process of gathering information to support the anticipated design of a new activity in the water sector. Through this RFI, USAID is seeking information from outside organizations to inform the design of the new USAID/Bangladesh Feed the Future Water Management Activity. This activity will support the sustainable management and utilization of water resources to meet the diverse water needs of communities, ecosystems, and economic activities in the Khulna, Barisal, and Sylhet Divisions. USAID is seeking responses to the questions of this RFI outlined below, USAID is not seeking technical or cost applications / proposals at this time. Responses to this RFI are voluntary. Respondents are free to address any or all of the below items, as well as provide additional information that they think is relevant to issues related to drinking and irrigation water, water resource management, water governance in Bangladesh especially for Khulna, Barisal, and Sylhet Divisions. USAID will not pay respondents for any information provided in response to this RFI. Any future solicitations of funding opportunities related to the Feed the Future Bangladesh Water Management Project will be announced on the Federal Business Opportunities website at www.sam.gov or at www.grants.gov at a later date. Please note that issuance of this RFI does not constitute an award commitment on the part of the U.S. Government, nor does it commit the Government to pay for any costs incurred in the preparation of comments.Amendment to RFI (Issued on 8/9/2024)The purpose of this amendment of the Request for Information (RFI) is to extend the submission timeline through August 31, 2024, 5:00 pm (Dhaka time). Please do not submit responses again if you have already submitted.

The DoD Kidney Cancer, Translational Research Partnership Award is a funding opportunity designed to support collaborative research projects between clinicians and scientists, with the aim of accelerating the development and application of innovative ideas in kidney cancer treatment and care, particularly those relevant to active-duty Service Members, Veterans, and the American public.

This grant provides funding for organizations to develop and implement comprehensive strategies that enhance the resilience of food systems and improve food security in various regions.

USAID/Cambodia is seeking applications for a Cooperative Agreement from qualified entities to implement the Cambodia Media Development (CMD) Activity. The purpose of this activity is to strengthen and expand the diversity of trustworthy news and information sources available to Cambodians so that they can be better equipped to participate in civic life. The CMD activity contains two main objectives: Objective 1: Institutionalization. Strengthen independent platforms for gathering and disseminating trustworthy news and information to Cambodian audiences. Objective 2: Innovation. Expand the means and methods used to bring Cambodians reliable, independent news and information.Objective 3: Resilience. Build the cohesion, security, and durability of Cambodias independent media sector.

U.S. Embassy Bern invites proposals for programs that strengthen cultural ties between the United States and Switzerland or Liechtenstein through cultural and exchange programming that highlights shared values and promotes bilateral cooperation and dialogue. All programs must include an American cultural element, or connection with (a) U.S. expert/s, organization/s, or institution/s in a specific field that will promote increased understanding of U.S. policy and perspectives. The PDS Small Grants Program is open to applications from Swiss, Liechtenstein, and U.S. organizations and individuals. We especially encourage and will prioritize applications from alumni of U.S. State Department Exchange Programs who are residents of Switzerland or Liechtenstein. Priority Program Areas: 1. Recognizing and countering disinformation and misinformation 2. Diversity, equity, inclusion, and accessibility, with a special focus on: 2.1. Women and girls, in all their diversity, in STEAM fields 2. 2.Increasing visibility, equity, inclusion, and accessibility of underrepresented groups in Switzerland and Liechtenstein, including immigrants, migrants, refugees, and asylees 3. Promoting mobility and knowledge transfer of apprenticeships between Switzerland/Liechtenstein and the United States 4. Strengthening entrepreneurship and economic collaboration between the United States and Switzerland with an emphasis on emerging and women entrepreneurs and business students Participants and Audiences: 1. Swiss and Liechtenstein residents 2. Underrepresented groups 3. Swiss and Liechtenstein youth aged 16 to 25 4. Emerging and established professionals and leaders in the priority program areas mentioned above Applicants should read the full description of the statement, attached here or on our website: https://ch.usembassy.gov/embassy/jobs/proposals/

This grant provides funding to civil society organizations and non-governmental groups in Uganda to strengthen media, promote civic education, and engage youth in governance processes.

Subject: Jordan RFI/SSN: Prevent, Detect, Respond - Primary Health Care (PDR-PHC) ActivityThe United States Agency for International Development in Jordan (USAID/Jordan) Mission isgathering information for a potential Global Health Security (GHS) activity. The Activity willinclude a package of interventions to strengthen biosecurity and safety, address antimicrobialresistance (AMR), and prevent and respond to emerging threats through building One Healthcapacities that incorporate linkages between human, animal, and environmental health.Through focusing its interventions at the primary healthcare level, the activity will strengthenhealth provider practices, health system preparedness, multi-sectoral coordination, andsurveillance capabilities to 1) prevent avoidable disease outbreaks, 2) detect threats early, 3)respond rapidly and effectively when outbreaks occur.This RFI/SSN seeks responses to the below inquiries as well as information on the availability,interest, and diverse capacities of GHS-focused entities to carry out such tasks and theirability to collaborate with local entities.This RFI/SSN is issued solely for information and planning purposes. It is NOT a Request forProposal (RFP), nor Notice of Funding Opportunity (NOFO), and in no way obligates the U.S.Government to issue an RFP/NOFO and/or award a contract/grant or pay for any informationsubmitted as a result of this request. If a solicitation is issued, all necessary information willbe supplied at the time it is posted at grants.gov or sam.gov.

The United States Agency for International Development (USAID) seeks Concept Notes (CNs) for a performance-based Leader Award Cooperative Agreement from qualified organizations to implement the USAID Feed the Future Demand And Supply for Safe, Healthy Diets (FTF DASHED) program.

The Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program is a funding opportunity aimed at providing financial assistance to metropolitan areas severely affected by HIV, with the goal of enhancing access to comprehensive, high-quality care for people with HIV and improving their health outcomes.

The grant titled "ROSES 2024: C.27 Lucy in the L4 Trojans Participating Scientist Program" is a funding opportunity by NASA's Science Mission Directorate for research and technology in space and Earth sciences, with a specific focus on the Lucy in the L4 Trojans project, and it invites proposals from various types of organizations, both domestic and foreign.

The Superior Health Foundation is currently accepting grant applications for its proactive grant-giving initiatives for 2023-2024. Donor Name: Superior Health Foundation (SHF) State: County: All Counties Type of Grant: Grant Deadline: (mm/dd/yyyy) 08/04/2024 Size of the Grant: More than $1 million Grant Duration: Grant Duration Not Mentioned Details: The Request For Proposals (RFP) to address pediatric mental health issues in the Upper Peninsula. The Superior Health Foundation — along with its funding partners, the Michigan Health Endowment Fund and the Blue Cross Blue Shield of Michigan Foundation — will award more than $1.3 million in grant funding to address Pediatric Mental Health. The Superior Health Foundation Grants Committee places a heavy emphasis on collaborative projects that have collective impact. For more information, visit Superior Health Foundation.

The United States Agency for International Developments (USAID) Mission to the Pacific Islands is developing a new program entitled Pacific Economic Growth Activity (PEG). The Regional Office of Acquisition and Assistance (ROAA)/USAID Pacific Islands has drafted preliminary technical requirements for the purpose of market research and also to provide industry implementers and stakeholders an opportunity to review, comment, suggest and enhance areas of the draft document. It also provides an advance opportunity for interested parties to establish teaming arrangements and identify key personnel in the event a solicitation is issued. It is anticipated that this technical requirements draft will result in a final Statement of Objectives or Program Description that may lead to a formal solicitation issued for response. It is anticipated that this requirement will result in two separate awards with an expected period of performance of five years within an award range of $15-$18 million for Papua New Guinea/Solomon Islands/Vanuatu (PNG/SI/VAN) and $18-$22 million for Fiji, Kiribati, Palau, Republic of Marshall Islands (RMI), Federated States of Micronesia (FSM), Nauru, Samoa, Tonga, and Tuvalu. Responses (comments, suggestions, and enhancements) to this RFI are due to the procurement office by July 24, 2024. Please email responses to [email protected]. Please include the subject title Response to PEG RFI in the e-mail subject line to ensure the response is directed appropriately.

Bipartisan Infrastructure Law (BIL) - Clean Fuels Products Shot: Supporting Carbon Utilization Products via Electrochemical Conversion and Refinery and Petrochemical Facilities Retrofitting The Office of Fossil Energy and Carbon Management (FECM) in collaboration with the National Energy Technology Laboratory (NETL) is issuing this Funding Opportunity Announcement (FOA). Awards made under this FOA will be funded, in whole or in part, with funds appropriated by the Infrastructure Investment and Jobs Act, more commonly known as the Bipartisan Infrastructure Law (BIL). The activities to be funded under this Funding Opportunity Announcement support BIL Section 40302. Research and Development funded under this Funding Opportunity Announcement will support the Departments Clean Fuels Products Shots initiative, which was established to support the national goal of achieving net-zero emissions by 2050 by developing the sustainable feedstocks and conversion technologies necessary to produce crucial fuels, materials, and carbon-based products that are better for the environment than current petroleum-derived components. It aims to meet projected 2050 net-zero emissions demands for 100 percent of aviation fuel; 50 percent of maritime, rail, and off-road fuel; and 50 percent of carbon-based chemicals by using sustainable carbon resources. Modification 000001: The purpose of this modification is to update wording within the Topic Area descriptions to clarify the Funding Opportunity Announcement does not restrict conversion of carbon oxides, change instances of "CO2" to "carbon" throughout the Funding Opportunity Announcement, and clarify the medium-term test requirement for Topic Area 1.

DE-FOA-0003323: Water Power Innovation Network AMENDMENT 000003: The purpose of this modification is to: Update the Expected Date for EERE Selection Notifications and Expected Timeframe for Award Negotiations. Add clarification to the down-select deliverable, Updated Budget, SOPO, and Project Schedule. Add clear requirements to the Content for the Full Application regarding what information to include for Budget Period 1 versus Budget Period 2. This includes the following changes: The Technical Volume Workplan should include goals, objectives, and anticipated outcomes for each budget period. The Technical Volume Workplan should include a detailed Workplan summary for Budget Period 1 and a preliminary high-level overview for Budget Period 2 of activities to be conducted over Budget Period 2. The Technical Volume Workplan should describe at least one end of project Specific, Measurable, Attainable, Realistic, and Timely (SMART) goal for each budget period. The Technical Volume Workplan should include a summary of appropriate milestones throughout each budget period. For Budget Period 2 milestones, however, it is sufficient to list approximate, reasonable estimates of what the milestones will be. It is understood that Budget Period 2 activities will be progressively developed over the course of Budget Period 1 and as such precise information on Budget Period 2 activities may not be available during the application process. Project applications will not be penalized for having a lower level of detail of Budget Period 2 activities during the application process. Rather, Budget Period 2 activities will be comprehensively evaluated during the down-select process at the end of Budget Period 1. The Technical Volume Workplan should include a detailed schedule for Budget Period 1 and a preliminary high-level/approximate schedule for Budget Period 2. As with the work plan, it is expected that the Budget Period 2 schedule will be developed over the course of Budget Period 1. Project applications will not be penalized for providing a lower level of detail during the application process. Rather, Budget Period 2 schedules will be comprehensively evaluated during the down-select process at the end of Budget Period 1. An updated associated SOPO template is provided. Add clarification to the Budget Justification Workbook for what to include for Budget Period 1 versus Budget Period 2. Update the Technical Review Criteria, Criterion 3: Workplan, to be consistent with the updates to the Technical Volume and associated SOPO. AMENDMENT 000002: The purpose of this modification is to provide clarity to the following areas and update the Statement of Project Objectives template: Added language that clarifies the proposed programming and services will be further developed during Budget Period 1. Added language that applicants proposed programs should provide incubation, acceleration, and commercialization support to entrepreneurs and small businesses in water power. Added language to the Content and Form of the Concept Paper and Full Application that clarifies the proposed program could be a new water power incubator or accelerator program, or could be an existing incubator or accelerator program that will be expanded upon in water power. Technical Volume Work Plan to focus on Budget Period 1. An associated SOPO template is provided. The Down-Select deliverable, Updated Budget, SOPO, and Project Schedule, should be updated to include information for Budget Period 2. AMENDMENT 000001: The purpose of this modification is to adjust the timeline for this FOA, which includes changes to the following dates: Submission Deadline for Concept Papers Submission Deadline for Full Applications Expected Date for EERE Selection Notifications Expected Timeframe for Award Negotiations The U.S. Department of Energys (DOE) Water Power Technologies Office (WPTO) is issuing this $4.8 million funding opportunity announcement (FOA) Water Power Innovation Network to support business creation, entrepreneurship, and regional innovation for water power systems and solutions. WPTO enables research, development, and testing of emerging technologies to advance marine energy as well as next-generation hydropower and pumped storage systems for a flexible, reliable grid. Through this FOA, WPTO seeks to fund new and/or expanded incubator or accelerator programs that enable entrepreneurship and accelerate water power innovation, business creation, and growth in communities and regions throughout the United States. Through this FOA, new and/or expanded incubators and accelerators in water power will be able to collaborate with one another and build a stronger water power innovation network in support of accelerating water power technologies to market. Topic Area 1: Water Power Incubation and Acceleration. This topic area will fund programs that accelerate the commercialization and adoption of water power systems and solutions through incubation and acceleration programming and services that support entrepreneurs and small businesses in marine energy and/or hydropower. Questions regarding the FOA must be submitted to [email protected]. To view the entire FOA document, visit the EERE Exchange Website at https://eere-exchange.energy.gov.

The FY24 KCRP Postdoctoral and Clinical Fellowship Award supports recent doctoral or medical school graduates in pursuit of innovative, high-impact kidney cancer research during their postdoctoral and/or clinical fellowship and allows them to obtain the necessary experience for an independent career as a leader in kidney cancer research. Applicants must demonstrate that the proposed research has high potential to lead to, or make, significant advancements in kidney cancer research and/or patient care. Applicants for this award must also exhibit a strong desire to pursue a career in kidney cancer research, with clear evidence for a researcher development plan that will lead to a successful independent career in kidney cancer. The critical components of this award mechanism are: Impact: Research supported by the FY24 KCRP Postdoctoral and Clinical Fellowship Award will have the potential for a major impact and accelerate progress toward ending kidney cancer. The impact may be short term or long term, but must move beyond an incremental advance. Applications are expected to identify the kidney cancer patients or at-risk individuals who would ultimately benefit from the proposed research. Research Strategy: The research proposed as part of the Postdoctoral and Clinical Fellowship Award must have high potential to lead to or make breakthroughs in kidney cancer. The scope of the research may include innovative, high-risk/high-reward research in the early stages of idea development or research already supported by preliminary data with the potential to make significant advancements toward clinical translation. The research strategy should demonstrate sound rationale, logical reasoning, and, if available, preliminary data. The proposed research should show evidence of rigorous experimental design, sufficient experimental details, appropriate controls, a statistical plan, and consideration of pitfalls and alternatives. Principal Investigator (PI): Under this award mechanism, the postdoctoral or clinical fellow is considered the PI and, as such, is expected to write the project narrative, researcher development plan, and other application components, with appropriate guidance from the mentor. While the PI is not required to have previous experience in kidney cancer research, the proposed project and researcher development plan must focus on kidney cancer. Applications must emphasize the PIs potential for success in becoming an independent kidney cancer researcher based on their qualifications, achievements/honors (including first-author publications and funding), and letters of recommendation. Mentor: The mentor (or co-mentor, if applicable) must possess the appropriate experience in kidney cancer research and/or patient care, to include recent publications and a record of active funding, and clearly demonstrate a commitment to guiding the PIs research and development as a researcher. If the mentor is not an experienced kidney cancer researcher, then formal co mentorship by an established kidney cancer researcher is required. The application must include information about the mentors experience in conducting innovative research and how they intend to support the PIs endeavors in kidney cancer. Mentorship by an investigator without an established record of mentoring pre- and/or postdoctoral trainees may be offset by the overall strength of the researcher development plan. Researcher Development Plan: Applications must provide details on the suitability of the PIs overall researcher development plan for attaining the goals of this award mechanism. Applications must elaborate on the qualities of the research environment in which the candidate will work, provide details on the individualized kidney cancer-focused researcher development plan, and describe how it will facilitate the PIs career development as an independent, innovative kidney cancer researcher. A multidisciplinary research approach to kidney cancer is highly encouraged, but not required; however, if there are multidisciplinary aspects, they should be clearly outlined in the application. Organizational-Level Emphasis: The following areas of emphasis are broadly applicable to many CDMRP programs, not just the KCRP. Investigators are encouraged to consider addressing these areas in their applications if doing so is appropriate for their line of research, addresses the FY24 KCRP strategic priorities and/or focus areas described in Section II.A.1 and Section II.A.2. Nuclear Medicine: Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies. Womens Health: CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women's health outcomes and/or advancing knowledge for women's health. Metastatic Cancer Task Force: A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 KCRP priorities. Rigorous Study Design: All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (https://www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies. Military Service Involvement: Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research. Research involving human subjects and human anatomical substances is permitted; however, clinical trials are not allowed under this program announcement. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials. For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes: (1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies. (2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. (3) Outcomes research and health services research that do not fit under the definition of clinical trial. Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule. The funding instrument for awards made under the program announcement will be grants (31 USC 6304). The anticipated direct costs budgeted for the entire period of performance for an FY24 KCRP Postdoctoral and Clinical Fellowship Award should not exceed $195,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. Awards supported with FY24 funds will be made no later than September 30, 2025. The CDMRP expects to allot approximately $2.18M to fund approximately seven Postdoctoral and Clinical Fellowship Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

The NFRP Synergistic Idea Award supports new ideas that represent synergistic approaches to NF research involving two or three Principal Investigators (PIs). These investigators should utilize their complementary and synergistic perspectives to address a central problem or question in NF research. This award is designed to support both new and pre-existing partnerships and encourages participation of PIs from other research fields. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.

The NFRP Investigator-Initiated Research Award supports highly rigorous, high-impact research projects that have the potential to make an important contribution to NF research and/or patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinicians firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.